03:57 AM EDT, 03/12/2026 (MT Newswires) -- Pharming ( PHAR ) reported Q4 earnings Thursday of $0.007 per diluted share, up from $0.004 a year earlier.

Three analysts polled by FactSet expected $0.00.

Revenue for the quarter ended Dec. 31 was $106.5 million, up from $92.7 million a year earlier.

Two analysts surveyed by FactSet expected $114.4 million.

For 2026, the company expects revenue of $405 million to $425 million. Analysts polled by FactSet expect $420 million.

Shares of the company were down 3.9% in premarket activity Thursday.